|
The effect of a trAnSitional Pharmacist Intervention in geRiatric inpatients on hospital visits after dischargE (ASPIRE): Protocol for a randomized controlled trial.
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift) |
|
ID |
4646629 |
Author(s) |
Julie, Hias; Laura, Hellemans; Annouschka, Laenen; Karolien, Walgraeve; Astrid, Liesenborghs; Sabina, De Geest; Jeroen, Luyten; Isabel, Spriet; Johan, Flamaing; der Linden Lorenz, Van; Jos, Tournoy |
Author(s) at UniBasel |
De Geest, Sabina M.
|
Year |
2022 |
Title |
The effect of a trAnSitional Pharmacist Intervention in geRiatric inpatients on hospital visits after dischargE (ASPIRE): Protocol for a randomized controlled trial. |
Journal |
Contemporary clinical trials |
Pages / Article-Number |
106853 |
Keywords |
80 and older; Aged; Clinical pharmacy intervention; Hospitalization; Inappropriate prescribing; Integrated Health Care Systems; Randomized controlled trial |
Abstract |
Unplanned rehospitalizations occur frequently in older patients. Drug-related problems constitute a major and largely preventable cause with inappropriate prescribing being a substantial culprit. Solutions are needed to reduce this risk by targeting pharmacotherapy both during and after hospital stay. Therefore, we aim to perform a randomized controlled trial in geriatric inpatients to investigate the impact of a multifaceted clinical pharmacy intervention on health-related outcomes.; The study concerns a monocenter, non-blinded, randomized controlled trial that will take place at the acute geriatric wards of a large academic hospital. Patients being in a palliative stage with active therapy withdrawal or patients discharged to another ward within the same hospital or another hospital are excluded. In total, 828 patients will be randomized (1:1) to the usual care or intervention group. The multifaceted clinical pharmacy intervention comprises medication reconciliation at admission and discharge, medication review, patient/caregiver education, intensified communication with primary care providers and post-discharge follow-up, which also includes a telepharmacology service. The primary endpoint is defined as the time to an all-cause, unplanned hospital revisit within six months after discharge. Other health-related outcomes such as drug-related readmissions, quality of life and number of potentially inappropriate medications will be analyzed as secondary endpoints. Patient inclusion started in February 2021.; This study will provide useful insights regarding the impact of clinical pharmacy interventions on geriatric wards with the goal to optimize health-related outcomes such as hospital revisits.; ClinicalTrials.gov Identifier: NCT04617340. |
ISSN/ISBN |
1559-2030 |
Full Text on edoc |
|
Digital Object Identifier DOI |
10.1016/j.cct.2022.106853 |
PubMed ID |
http://www.ncbi.nlm.nih.gov/pubmed/35842106 |
|
|
|
MCSS v5.8 PRO. 0.412 sec, queries - 0.000 sec
©Universität Basel | Impressum
| |
06/05/2024
Research Database / FORSCHUNGSDATENBANK
|